SG1906 for CLDN18.2-Positive Solid Tumors
SG1906 for CLDN18.2-Positive Solid Tumors
Recruiting · NCT05857332 · Registry updated 2026-08-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SG1906 for CLDN18.2-Positive Solid Tumors | Locally Advanced Unresectable or Metastatic Solid Tumors | Recruiting | Phase 1 | 2026-08-11 | NCT05857332 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hangzhou Sumgen Biotech Co., Ltd. | 8 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chinese PLA General Hospital | Beijing | China | 6 |
| Henan Cancer Hospital | Zhengzhou | China | 57 |
| Liaoning Cancer Hospital | Shenyang | China | 9 |
| Shanxi Cancer Hospital | Taiyuan | China | 19 |
| The First Affiliated Hospital Of Xiamen University | Xiamen | China | 50 |
| The first Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou | China | 69 |
| The First Hospital of China Medical University | Shenyang | China | 12 |
| The Second Affiliated Hospital Zhejiang University School of Medicine | Hangzhou | China | 33 |
| The Sixth Affiliated hospital, Sun Yat-sen University | Guangzhou | China | 23 |